Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

November 30, 2025

Conditions
Uterine FibroidsHysteroscopic MyomectomyTreatment CompliancePatient ComplianceTreatment Complication
Interventions
PROCEDURE

Hysteroscopic myomectomy

"The hysteroscopic myomectomies were conducted during the follicular phase of the menstrual cycle. Throughout the surgical procedure, the intrauterine pressure was meticulously maintained at less than 80 mm Hg. Data on the duration of the surgical intervention, the volume of fluid administered, and the volume of fluid absorbed were collected. Complete resection was characterized as the total excision of the myoma. The determination of the completeness of myomectomy was made by the experienced surgeon during the surgical process. In instances where the resection was deemed incomplete, the decision to pursue a secondary surgical intervention was predicated on ultrasonographic evaluations, the symptomatic presentation of the patients, and, in certain circumstances, the findings from diagnostic hysteroscopy. Cases in which access to the uterine cavity was unfeasible were classified as failed procedures and were subsequently excluded from the study."

Trial Locations (1)

73020

Ospedale Veris delli Ponti, Scorrano

All Listed Sponsors
lead

Centro di Ricerca Clinica Salentino

NETWORK

NCT06768086 - Preoperative Administration of EGCG, Vitamin D and DCI Prior Hysteroscopic Myomectomy | Biotech Hunter | Biotech Hunter